If stabilization of IDE substrates by an N-terminal Pro-1 is possible in principle, this might also be of interest to increase the half-life of insulin preparations and thereby to enhance bioavailability of administered insulin in diabetes patients. This evidence concerns the gene INS and diabetes mellitus.